Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Repeated social defeat stress impairs attentional set shifting irrespective of social avoidance and increases female preference associated with heightened anxiety.

Higashida S, Nagai H, Nakayama K, Shinohara R, Taniguchi M, Nagai M, Hikida T, Yawata S, Ago Y, Kitaoka S, Narumiya S, Furuyashiki T.

Sci Rep. 2018 Jul 11;8(1):10454. doi: 10.1038/s41598-018-28803-1.

2.

[Pathophysiological implication of the VPAC2 receptor in psychiatric disorders].

Ago Y, Hayata A, Hashimoto H.

Nihon Yakurigaku Zasshi. 2018;151(6):249-253. doi: 10.1254/fpj.151.249. Japanese.

PMID:
29887574
3.

β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking.

Shintani Y, Hayata-Takano A, Moriguchi K, Nakazawa T, Ago Y, Kasai A, Seiriki K, Shintani N, Hashimoto H.

PLoS One. 2018 May 7;13(5):e0196946. doi: 10.1371/journal.pone.0196946. eCollection 2018.

4.

Intronic antisense Alu elements have a negative splicing effect on the inclusion of adjacent downstream exons.

Nakama M, Otsuka H, Ago Y, Sasai H, Abdelkreem E, Aoyama Y, Fukao T.

Gene. 2018 Jul 20;664:84-89. doi: 10.1016/j.gene.2018.04.064. Epub 2018 Apr 23.

PMID:
29698748
5.

Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism.

Inoue N, Ogura S, Kasai A, Nakazawa T, Ikeda K, Higashi S, Isotani A, Baba K, Mochizuki H, Fujimura H, Ago Y, Hayata-Takano A, Seiriki K, Shintani Y, Shintani N, Hashimoto H.

EMBO Rep. 2018 Mar;19(3). pii: e44860. doi: 10.15252/embr.201744860. Epub 2018 Jan 25.

PMID:
29371327
6.

Impaired extinction of cued fear memory and abnormal dendritic morphology in the prelimbic and infralimbic cortices in VPAC2 receptor (VIPR2)-deficient mice.

Ago Y, Hayata-Takano A, Kawanai T, Yamauchi R, Takeuchi S, Cushman JD, Rajbhandari AK, Fanselow MS, Hashimoto H, Waschek JA.

Neurobiol Learn Mem. 2017 Nov;145:222-231. doi: 10.1016/j.nlm.2017.10.010. Epub 2017 Oct 10.

PMID:
29030297
7.

Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism.

Hara Y, Ago Y, Higuchi M, Hasebe S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K.

Horm Behav. 2017 Nov;96:130-136. doi: 10.1016/j.yhbeh.2017.09.013. Epub 2017 Sep 28.

PMID:
28942000
8.

Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.

Hara Y, Ago Y, Taruta A, Hasebe S, Kawase H, Tanabe W, Tsukada S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K.

Psychopharmacology (Berl). 2017 Nov;234(21):3217-3228. doi: 10.1007/s00213-017-4703-9. Epub 2017 Aug 10.

PMID:
28798977
9.

Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain.

Hara Y, Ago Y, Takano E, Hasebe S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K.

Mol Autism. 2017 Jun 28;8:33. doi: 10.1186/s13229-017-0149-5. eCollection 2017.

10.

Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.

Yamaguchi H, Hara Y, Ago Y, Takano E, Hasebe S, Nakazawa T, Hashimoto H, Matsuda T, Takuma K.

Behav Brain Res. 2017 Aug 30;333:67-73. doi: 10.1016/j.bbr.2017.06.035. Epub 2017 Jun 24.

PMID:
28655565
11.

High-Speed and Scalable Whole-Brain Imaging in Rodents and Primates.

Seiriki K, Kasai A, Hashimoto T, Schulze W, Niu M, Yamaguchi S, Nakazawa T, Inoue KI, Uezono S, Takada M, Naka Y, Igarashi H, Tanuma M, Waschek JA, Ago Y, Tanaka KF, Hayata-Takano A, Nagayasu K, Shintani N, Hashimoto R, Kunii Y, Hino M, Matsumoto J, Yabe H, Nagai T, Fujita K, Matsuda T, Takuma K, Baba A, Hashimoto H.

Neuron. 2017 Jun 21;94(6):1085-1100.e6. doi: 10.1016/j.neuron.2017.05.017.

12.

Psychopharmacology of combined activation of the serotonin1A and σ1 receptors.

Ago Y, Hasebe S, Hiramatsu N, Hashimoto H, Takuma K, Matsuda T.

Eur J Pharmacol. 2017 Aug 15;809:172-177. doi: 10.1016/j.ejphar.2017.05.035. Epub 2017 May 18. Review.

PMID:
28529139
13.

Decreased cohesin in the brain leads to defective synapse development and anxiety-related behavior.

Fujita Y, Masuda K, Bando M, Nakato R, Katou Y, Tanaka T, Nakayama M, Takao K, Miyakawa T, Tanaka T, Ago Y, Hashimoto H, Shirahige K, Yamashita T.

J Exp Med. 2017 May 1;214(5):1431-1452. doi: 10.1084/jem.20161517. Epub 2017 Apr 13.

14.

Regulation of emotional behaviors by juvenile environmental factors.

Takuma K, Ago Y, Hasebe S, Nakazawa T, Hashimoto H, Matsuda T.

Nihon Yakurigaku Zasshi. 2017;149(2):76-78. doi: 10.1254/fpj.149.76. Japanese. No abstract available.

PMID:
28154301
15.

Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.

Tanaka T, Ago Y, Umehara C, Imoto E, Hasebe S, Hashimoto H, Takuma K, Matsuda T.

Int J Neuropsychopharmacol. 2017 May 1;20(5):410-421. doi: 10.1093/ijnp/pyw115.

16.

Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice.

Hasebe S, Ago Y, Watabe Y, Oka S, Hiramatsu N, Tanaka T, Umehara C, Hashimoto H, Takuma K, Matsuda T.

Br J Pharmacol. 2017 Feb;174(4):314-327. doi: 10.1111/bph.13692. Epub 2017 Jan 26.

17.

Distribution of Silver Nanoparticles to Breast Milk and Their Biological Effects on Breast-Fed Offspring Mice.

Morishita Y, Yoshioka Y, Takimura Y, Shimizu Y, Namba Y, Nojiri N, Ishizaka T, Takao K, Yamashita F, Takuma K, Ago Y, Nagano K, Mukai Y, Kamada H, Tsunoda S, Saito S, Matsuda T, Hashida M, Miyakawa T, Higashisaka K, Tsutsumi Y.

ACS Nano. 2016 Sep 27;10(9):8180-91. doi: 10.1021/acsnano.6b01782. Epub 2016 Aug 15.

PMID:
27498759
18.

Prostaglandin D2 signaling mediated by the CRTH2 receptor is involved in MK-801-induced cognitive dysfunction.

Onaka Y, Shintani N, Nakazawa T, Kanoh T, Ago Y, Matsuda T, Hashimoto R, Ohi K, Hirai H, Nagata KY, Nakamura M, Kasai A, Hayata-Takano A, Nagayasu K, Takuma K, Ogawa A, Baba A, Hashimoto H.

Behav Brain Res. 2016 Nov 1;314:77-86. doi: 10.1016/j.bbr.2016.07.050. Epub 2016 Jul 29.

PMID:
27481693
19.

Involvement of GABAA receptors in 5-HT1A and σ1 receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency.

Ago Y, Hasebe S, Hiramatsu N, Mori K, Watabe Y, Onaka Y, Hashimoto H, Takuma K, Matsuda T.

Psychopharmacology (Berl). 2016 Sep;233(17):3125-34. doi: 10.1007/s00213-016-4353-3. Epub 2016 Jun 23.

PMID:
27339616
20.

Prenatal Exposure to Histone Deacetylase Inhibitors Affects Gene Expression of Autism-Related Molecules and Delays Neuronal Maturation.

Kawanai T, Ago Y, Watanabe R, Inoue A, Taruta A, Onaka Y, Hasebe S, Hashimoto H, Matsuda T, Takuma K.

Neurochem Res. 2016 Oct;41(10):2574-2584. Epub 2016 Jun 14.

PMID:
27300699
21.

High-resolution characterization of a PACAP-EGFP transgenic mouse model for mapping PACAP-expressing neurons.

Condro MC, Matynia A, Foster NN, Ago Y, Rajbhandari AK, Van C, Jayaram B, Parikh S, Diep AL, Nguyen E, May V, Dong HW, Waschek JA.

J Comp Neurol. 2016 Dec 15;524(18):3827-3848. doi: 10.1002/cne.24035. Epub 2016 Jun 3.

22.

[The novel method female encounter test].

Ago Y, Hasebe S, Hashimoto H, Takuma K, Matsuda T.

Nihon Yakurigaku Zasshi. 2016 Apr;147(4):230-4. doi: 10.1254/fpj.147.230. Japanese. No abstract available.

PMID:
27063907
23.

Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.

Hara Y, Ago Y, Taruta A, Katashiba K, Hasebe S, Takano E, Onaka Y, Hashimoto H, Matsuda T, Takuma K.

Autism Res. 2016 Sep;9(9):926-39. doi: 10.1002/aur.1596. Epub 2015 Dec 30.

PMID:
26714434
24.

Rivastigmine improves isolation rearing-induced prepulse inhibition deficits via muscarinic acetylcholine receptors in mice.

Higashino K, Ago Y, Umeki T, Hasebe S, Onaka Y, Hashimoto H, Takuma K, Matsuda T.

Psychopharmacology (Berl). 2016 Feb;233(3):521-8. doi: 10.1007/s00213-015-4123-7. Epub 2015 Oct 31.

PMID:
26518025
25.

Decreased expression of hippocampal Na⁺/Ca²⁺ exchanger isoform-1 by pentylenetetrazole kindling in mice.

Kawanai T, Taruta A, Inoue A, Watanabe R, Ago Y, Hashimoto H, Hasebe S, Ooi Y, Takuma K, Matsuda T.

Epilepsy Res. 2015 Sep;115:109-12. doi: 10.1016/j.eplepsyres.2015.06.002. Epub 2015 Jun 5.

PMID:
26220386
26.

[JSNP Excellent Presentation Award for CINP2014: PACAP].

Hayata A, Hazama K, Moriguchi K, Ago Y, Encho N, Nakazawa T, Nagayasu K, Kasai A, Onaka Y, Shintani N, Baba A, Hashimoto H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2015 Apr;35(2):55-6. Japanese. No abstract available.

PMID:
26027071
27.

The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in Mice.

Ago Y, Hasebe S, Nishiyama S, Oka S, Onaka Y, Hashimoto H, Takuma K, Matsuda T.

Int J Neuropsychopharmacol. 2015 May 29;18(11):pyv062. doi: 10.1093/ijnp/pyv062.

28.

Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice.

Hasebe S, Ago Y, Nishiyama S, Oka S, Hashimoto H, Takuma K, Matsuda T.

Behav Pharmacol. 2015 Oct;26(7 Spec No):681-90. doi: 10.1097/FBP.0000000000000140.

PMID:
25932719
29.

p13 overexpression in pancreatic β-cells ameliorates type 2 diabetes in high-fat-fed mice.

Higashi S, Katagi K, Shintani N, Ikeda K, Sugimoto Y, Tsuchiya S, Inoue N, Tanaka S, Koumoto M, Kasai A, Nakazawa T, Hayata-Takano A, Hamagami K, Tomimoto S, Yoshida T, Ohkubo T, Nagayasu K, Ago Y, Onaka Y, Hashimoto R, Ichikawa A, Baba A, Hashimoto H.

Biochem Biophys Res Commun. 2015 Jun 12;461(4):612-7. doi: 10.1016/j.bbrc.2015.04.074. Epub 2015 Apr 23.

PMID:
25912136
30.

Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model.

Hara Y, Takuma K, Takano E, Katashiba K, Taruta A, Higashino K, Hashimoto H, Ago Y, Matsuda T.

Behav Brain Res. 2015 Aug 1;289:39-47. doi: 10.1016/j.bbr.2015.04.022. Epub 2015 Apr 20.

PMID:
25907743
31.

Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.

Shibasaki Y, Hayata-Takano A, Hazama K, Nakazawa T, Shintani N, Kasai A, Nagayasu K, Hashimoto R, Tanida M, Katayama T, Matsuzaki S, Yamada K, Taniike M, Onaka Y, Ago Y, Waschek JA, Köves K, Reglődi D, Tamas A, Matsuda T, Baba A, Hashimoto H.

Neuroscience. 2015 Jun 25;297:95-104. doi: 10.1016/j.neuroscience.2015.03.062. Epub 2015 Apr 1.

PMID:
25841321
32.

PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF.

Ogata K, Shintani N, Hayata-Takano A, Kamo T, Higashi S, Seiriki K, Momosaki H, Vaudry D, Vaudry H, Galas L, Kasai A, Nagayasu K, Nakazawa T, Hashimoto R, Ago Y, Matsuda T, Baba A, Hashimoto H.

PLoS One. 2015 Mar 25;10(3):e0120526. doi: 10.1371/journal.pone.0120526. eCollection 2015.

33.

Role of the 5-HT1A autoreceptor in the enhancement of fluvoxamine-induced increases in prefrontal dopamine release by adrenalectomy/castration in mice.

Hasebe S, Hiramatsu N, Ago Y, Mori K, Watabe Y, Hashimoto H, Takuma K, Matsuda T.

J Pharmacol Sci. 2015 Feb;127(2):232-5. doi: 10.1016/j.jphs.2015.01.001. Epub 2015 Jan 13.

34.

Simultaneous neuron- and astrocyte-specific fluorescent marking.

Schulze W, Hayata-Takano A, Kamo T, Nakazawa T, Nagayasu K, Kasai A, Seiriki K, Shintani N, Ago Y, Farfan C, Hashimoto R, Baba A, Hashimoto H.

Biochem Biophys Res Commun. 2015 Mar 27;459(1):81-6. doi: 10.1016/j.bbrc.2015.02.073. Epub 2015 Feb 24.

PMID:
25721661
35.

Shp2 in forebrain neurons regulates synaptic plasticity, locomotion, and memory formation in mice.

Kusakari S, Saitow F, Ago Y, Shibasaki K, Sato-Hashimoto M, Matsuzaki Y, Kotani T, Murata Y, Hirai H, Matsuda T, Suzuki H, Matozaki T, Ohnishi H.

Mol Cell Biol. 2015 May;35(9):1557-72. doi: 10.1128/MCB.01339-14. Epub 2015 Feb 23.

36.

CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice.

Onaka Y, Shintani N, Nakazawa T, Haba R, Ago Y, Wang H, Kanoh T, Hayata-Takano A, Hirai H, Nagata KY, Nakamura M, Hashimoto R, Matsuda T, Waschek JA, Kasai A, Nagayasu K, Baba A, Hashimoto H.

Behav Brain Res. 2015 May 1;284:131-7. doi: 10.1016/j.bbr.2015.02.013. Epub 2015 Feb 16.

PMID:
25698598
37.

Anxiolytic-like effects of restraint during the dark cycle in adolescent mice.

Ota Y, Ago Y, Tanaka T, Hasebe S, Toratani Y, Onaka Y, Hashimoto H, Takuma K, Matsuda T.

Behav Brain Res. 2015 May 1;284:103-11. doi: 10.1016/j.bbr.2015.02.010. Epub 2015 Feb 14.

PMID:
25687845
38.

Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist.

Ago Y, Condro MC, Tan YV, Ghiani CA, Colwell CS, Cushman JD, Fanselow MS, Hashimoto H, Waschek JA.

Psychopharmacology (Berl). 2015 Jun;232(12):2181-9. doi: 10.1007/s00213-014-3848-z. Epub 2015 Jan 11.

39.

Identification of the role of bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) signaling in the trajectory of serotonergic differentiation in a rapid assay in mouse embryonic stem cells in vitro.

Yamasaki A, Kasai A, Toi A, Kurita M, Kimoto S, Hayata-Takano A, Nakazawa T, Nagayasu K, Shintani N, Hashimoto R, Ito A, Meltzer HY, Ago Y, Waschek JA, Onaka Y, Matsuda T, Baba A, Hashimoto H.

J Neurochem. 2015 Feb;132(4):418-28. doi: 10.1111/jnc.12999. Epub 2015 Jan 23.

40.

Behavioral characterization of mice overexpressing human dysbindin-1.

Shintani N, Onaka Y, Hashimoto R, Takamura H, Nagata T, Umeda-Yano S, Mouri A, Mamiya T, Haba R, Matsuzaki S, Katayama T, Yamamori H, Nakazawa T, Nagayasu K, Ago Y, Yagasaki Y, Nabeshima T, Takeda M, Hashimoto H.

Mol Brain. 2014 Oct 9;7:74. doi: 10.1186/s13041-014-0074-x.

41.

[Neurochemical basis for social encounter-induced hyperactivity in post-weaning isolation-reared mice].

Ago Y.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2014 Aug;34(4):101-7. Review. Japanese.

PMID:
25255643
42.

Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism.

Takuma K, Hara Y, Kataoka S, Kawanai T, Maeda Y, Watanabe R, Takano E, Hayata-Takano A, Hashimoto H, Ago Y, Matsuda T.

Pharmacol Biochem Behav. 2014 Nov;126:43-9. doi: 10.1016/j.pbb.2014.08.013. Epub 2014 Sep 18.

PMID:
25240644
43.

[Haploinsufficiency of the T-box transcription factor Tbr1].

Ago Y.

Nihon Yakurigaku Zasshi. 2014 Sep;144(3):146. Japanese. No abstract available.

PMID:
25213616
44.

An enriched environment ameliorates memory impairments in PACAP-deficient mice.

Takuma K, Maeda Y, Ago Y, Ishihama T, Takemoto K, Nakagawa A, Shintani N, Hashimoto H, Baba A, Matsuda T.

Behav Brain Res. 2014 Oct 1;272:269-78. doi: 10.1016/j.bbr.2014.07.005. Epub 2014 Jul 9.

PMID:
25014004
45.

The role of Pak-interacting exchange factor-β phosphorylation at serines 340 and 583 by PKCγ in dopamine release.

Shirafuji T, Ueyama T, Yoshino K, Takahashi H, Adachi N, Ago Y, Koda K, Nashida T, Hiramatsu N, Matsuda T, Toda T, Sakai N, Saito N.

J Neurosci. 2014 Jul 9;34(28):9268-80. doi: 10.1523/JNEUROSCI.4278-13.2014.

46.

[Transitive inference task in mice using a touchscreen assay].

Ago Y.

Nihon Yakurigaku Zasshi. 2014 Jul;144(1):45. Japanese. No abstract available.

PMID:
25007812
47.

Potential role of serotonin1A receptors in post-weaning social isolation-induced abnormal behaviors in rodents.

Ago Y, Takuma K, Matsuda T.

J Pharmacol Sci. 2014;125(3):237-41. Epub 2014 Jun 18. Review.

48.

Galantamine promotes adult hippocampal neurogenesis via M₁ muscarinic and α7 nicotinic receptors in mice.

Kita Y, Ago Y, Higashino K, Asada K, Takano E, Takuma K, Matsuda T.

Int J Neuropsychopharmacol. 2014 Dec;17(12):1957-68. doi: 10.1017/S1461145714000613. Epub 2014 May 12.

PMID:
24818616
49.

Social crowding in the night-time reduces an anxiety-like behavior and increases social interaction in adolescent mice.

Ago Y, Tanaka T, Ota Y, Kitamoto M, Imoto E, Takuma K, Matsuda T.

Behav Brain Res. 2014 Aug 15;270:37-46. doi: 10.1016/j.bbr.2014.04.047. Epub 2014 May 4.

PMID:
24803212
50.

Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.

Ago Y, Umehara M, Higashino K, Hasebe S, Fujita K, Takuma K, Matsuda T.

Neurochem Res. 2014 May;39(5):825-32. doi: 10.1007/s11064-014-1275-5. Epub 2014 Mar 15.

PMID:
24634253

Supplemental Content

Support Center